Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

On CNBC's “ Halftime Report Final Trades ,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. GILD +0.78% Get Free Report is one of the best-performing names in one of the best-performing ...

Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

With the FDA appearing to be undergoing major disruption under new leadership, BofA analyst Tim Anderson says one way to assess the risk from ...

The Town pays $400,000 to send 18 Gilead children to school, said Town Clerk Patsy Cox, who added that they would not have a ...

Hulu announced that it is developing a series based on Margaret Atwood's 2019 novel "The Testaments," which is a follow-up to ...

Bruce Miller knew for a long time how he wanted to bring the story to a conclusion,' says EP Eric Tuchman. 'It's about June's ...

Welcome back to Gilead. “The Handmaid’s Tale” sequel series “The Testaments” has officially received a series order from Hulu ...